The popularity of Sildenafil initially sparked a surge for pharma, nevertheless recent changes present a murky scenario for investors. Off-patent competitors are eating into revenue, and continued legal battles add https://brontevbal439324.bloggadores.com/40000694/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-play